tenk.fyi

RELMADA THERAPEUTICS, INC.

RLMDNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$80.0M

19.0% YoY

EPS

$-2.65

19.2% YoY

Cash

$3.9M

5.7% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro